Non-invasive prenatal testing: use of cell-free fetal DNA in Down syndrome screening.
作者信息
Rafi Imran, Hill Melissa, Hayward Judith, Chitty Lyn S
机构信息
Senior Lecturer Primary Care Education, St George's University of London, London.
Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children NHS Foundation Trust, London.
出版信息
Br J Gen Pract. 2017 Jul;67(660):298-299. doi: 10.3399/bjgp17X691625.
Abstract
摘要
相似文献
1
Non-invasive prenatal testing: use of cell-free fetal DNA in Down syndrome screening.
Br J Gen Pract. 2017 Jul;67(660):298-299. doi: 10.3399/bjgp17X691625.
2
Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
Genet Res (Camb). 2019 Dec 9;101:e11. doi: 10.1017/S0016672319000119.
3
Update in non-invasive prenatal testing.
Minerva Ginecol. 2019 Feb;71(1):44-53. doi: 10.23736/S0026-4784.18.04306-X. Epub 2018 Oct 11.
4
Pregnant women support extra screening test for Down's syndrome.
BMJ. 2014 Sep 23;349:g5830. doi: 10.1136/bmj.g5830.
5
Rethinking second-trimester Down-syndrome screening in the cell-free DNA era.
Ultrasound Obstet Gynecol. 2019 Oct;54(4):431-436. doi: 10.1002/uog.20360.
6
Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing.
Clin Epigenetics. 2020 Oct 20;12(1):153. doi: 10.1186/s13148-020-00938-x.
7
Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
Hum Genomics. 2020 Jun 5;14(1):21. doi: 10.1186/s40246-020-00268-2.
8
Non-invasive prenatal testing.
Aust Fam Physician. 2017 Oct;46(10):735-739.
9
Cell-free DNA screening for aneuploidies in 7113 pregnancies: single Italian centre study.
Genet Res (Camb). 2020 Jun 16;102:e5. doi: 10.1017/S001667232000004X.
10
Potentially effective method for fetal gender determination by noninvasive prenatal testing for X-linked disease.
Congenit Anom (Kyoto). 2019 May;59(3):88-92. doi: 10.1111/cga.12302. Epub 2018 Jul 6.
引用本文的文献
1
High tissue specificity of lncRNAs maximises the prediction of tissue of origin of circulating DNA.
Sci Rep. 2025 Apr 15;15(1):12941. doi: 10.1038/s41598-024-82393-9.
2
Advancement in predictive biomarkers for gestational diabetes mellitus diagnosis and related outcomes: a scoping review.
BMJ Open. 2024 Dec 15;14(12):e089937. doi: 10.1136/bmjopen-2024-089937.
3
Integration of genomic medicine to mainstream patient care within the UK National Health Service.
Ulster Med J. 2024 Nov;93(3):111-118. Epub 2024 Nov 26.
4
Early Non-Invasive Prenatal Testing at 6-9 Weeks of Gestation.
Genes (Basel). 2024 Jul 8;15(7):895. doi: 10.3390/genes15070895.
5
Potential efficacy of digital polymerase chain reaction for non-invasive prenatal screening of autosomal aneuploidies: a systematic review and meta-analysis.
BMC Pregnancy Childbirth. 2024 Jul 11;24(1):472. doi: 10.1186/s12884-024-06655-0.
6
DNA Hyperstructure.
ACS Omega. 2024 Feb 12;9(8):9013-9026. doi: 10.1021/acsomega.3c07379. eCollection 2024 Feb 27.
7
DNA Methylation in the Fields of Prenatal Diagnosis and Early Detection of Cancers.
Int J Mol Sci. 2023 Jul 20;24(14):11715. doi: 10.3390/ijms241411715.
8
Non-Invasive prenatal testing with rolling circle amplification: Real-world clinical experience in a non-molecular laboratory.
J Clin Lab Anal. 2023 Mar;37(6):e24870. doi: 10.1002/jcla.24870. Epub 2023 Mar 27.
9
Cell-Free Fetal Deoxyribonucleic Acid (cffDNA) Analysis as a Remarkable Method of Non-Invasive Prenatal Screening.
Cureus. 2022 Oct 5;14(10):e29965. doi: 10.7759/cureus.29965. eCollection 2022 Oct.
10
Cell-free DNA screening for rare autosomal trisomies and segmental chromosome imbalances.
Prenat Diagn. 2022 Oct;42(11):1349-1357. doi: 10.1002/pd.6233. Epub 2022 Sep 22.
本文引用的文献
1
Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.
BMJ. 2016 Jul 4;354:i3426. doi: 10.1136/bmj.i3426.
2
Stakeholder attitudes and needs regarding cell-free fetal DNA testing.
Curr Opin Obstet Gynecol. 2016 Apr;28(2):125-31. doi: 10.1097/GCO.0000000000000251.
3
Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis.
BMJ Open. 2016 Jan 18;6(1):e010002. doi: 10.1136/bmjopen-2015-010002.
4
Global perspectives on clinical adoption of NIPT.
Prenat Diagn. 2015 Oct;35(10):959-67. doi: 10.1002/pd.4637. Epub 2015 Sep 25.
5
Overview of the impact of noninvasive prenatal testing on diagnostic procedures.
Prenat Diagn. 2015 Oct;35(10):972-9. doi: 10.1002/pd.4601. Epub 2015 May 21.
6
Cell-free DNA analysis for noninvasive examination of trisomy.
N Engl J Med. 2015 Apr 23;372(17):1589-97. doi: 10.1056/NEJMoa1407349. Epub 2015 Apr 1.
7
Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.
Eur J Hum Genet. 2015 Nov;23(11):1438-50. doi: 10.1038/ejhg.2015.57. Epub 2015 Mar 18.
8
Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
Ultrasound Obstet Gynecol. 2015 Mar;45(3):249-66. doi: 10.1002/uog.14791. Epub 2015 Feb 1.
9
Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases.
Genet Med. 2015 Mar;17(3):234-6. doi: 10.1038/gim.2014.92. Epub 2014 Aug 7.
10
Screening for fetal aneuploidies at 11 to 13 weeks.
Prenat Diagn. 2011 Jan;31(1):7-15. doi: 10.1002/pd.2637.
Zotero 插件